198 related articles for article (PubMed ID: 22344885)
1. Improving T₁ and T₂ magnetic resonance imaging contrast agents through the conjugation of an esteramide dendrimer to high-water-coordination Gd(III) hydroxypyridinone complexes.
Klemm PJ; Floyd WC; Smiles DE; Fréchet JM; Raymond KN
Contrast Media Mol Imaging; 2012; 7(1):95-9. PubMed ID: 22344885
[TBL] [Abstract][Full Text] [Related]
2. Conjugation effects of various linkers on Gd(III) MRI contrast agents with dendrimers: optimizing the hydroxypyridinonate (HOPO) ligands with nontoxic, degradable esteramide (EA) dendrimers for high relaxivity.
Floyd WC; Klemm PJ; Smiles DE; Kohlgruber AC; Pierre VC; Mynar JL; Fréchet JM; Raymond KN
J Am Chem Soc; 2011 Mar; 133(8):2390-3. PubMed ID: 21294571
[TBL] [Abstract][Full Text] [Related]
3. Substituent effects on Gd(III)-based MRI contrast agents: optimizing the stability and selectivity of the complex and the number of coordinated water molecules.
Pierre VC; Botta M; Aime S; Raymond KN
Inorg Chem; 2006 Oct; 45(20):8355-64. PubMed ID: 16999435
[TBL] [Abstract][Full Text] [Related]
4. Poly(amidoamine) dendrimer based MRI contrast agents exhibiting enhanced relaxivities derived via metal preligation techniques.
Nwe K; Bryant LH; Brechbiel MW
Bioconjug Chem; 2010 Jun; 21(6):1014-7. PubMed ID: 20462240
[TBL] [Abstract][Full Text] [Related]
5. Preparation, characterization and in vivo assessment of Gd-albumin and Gd-dendrimer conjugates as intravascular contrast-enhancing agents for MRI.
Nwe K; Milenic D; Bryant LH; Regino CA; Brechbiel MW
J Inorg Biochem; 2011 May; 105(5):722-7. PubMed ID: 21463567
[TBL] [Abstract][Full Text] [Related]
6. High-relaxivity MRI contrast agents: where coordination chemistry meets medical imaging.
Werner EJ; Datta A; Jocher CJ; Raymond KN
Angew Chem Int Ed Engl; 2008; 47(45):8568-80. PubMed ID: 18825758
[TBL] [Abstract][Full Text] [Related]
7. Gd-hydroxypyridinone (HOPO)-based high-relaxivity magnetic resonance imaging (MRI) contrast agents.
Datta A; Raymond KN
Acc Chem Res; 2009 Jul; 42(7):938-47. PubMed ID: 19505089
[TBL] [Abstract][Full Text] [Related]
8. Tuning the coordination number of hydroxypyridonate-based gadolinium complexes: implications for MRI contrast agents.
Pierre VC; Botta M; Aime S; Raymond KN
J Am Chem Soc; 2006 Apr; 128(16):5344-5. PubMed ID: 16620097
[TBL] [Abstract][Full Text] [Related]
9. Efficient relaxivity enhancement in dendritic gadolinium complexes: effective motional coupling in medium molecular weight conjugates.
Fulton DA; O'Halloran M; Parker D; Senanayake K; Botta M; Aime S
Chem Commun (Camb); 2005 Jan; (4):474-6. PubMed ID: 15654374
[TBL] [Abstract][Full Text] [Related]
10. Gadolinium complexes of monophosphinic acid DOTA derivatives conjugated to cyclodextrin scaffolds: efficient MRI contrast agents for higher magnetic fields.
Kotková Z; Helm L; Kotek J; Hermann P; Lukeš I
Dalton Trans; 2012 Nov; 41(43):13509-19. PubMed ID: 23018269
[TBL] [Abstract][Full Text] [Related]
11. Gadolinium(III) 1,2-hydroxypyridonate-based complexes: toward MRI contrast agents of high relaxivity.
Xu J; Churchill DG; Botta M; Raymond KN
Inorg Chem; 2004 Sep; 43(18):5492-4. PubMed ID: 15332797
[TBL] [Abstract][Full Text] [Related]
12. Syntheses and relaxation properties of mixed gadolinium hydroxypyridinonate MRI contrast agents.
Cohen SM; Xu J; Radkov E; Raymond KN; Botta M; Barge A; Aime S
Inorg Chem; 2000 Dec; 39(25):5747-56. PubMed ID: 11151375
[TBL] [Abstract][Full Text] [Related]
13. Gd(DOTAla): a single amino acid Gd-complex as a modular tool for high relaxivity MR contrast agent development.
Boros E; Polasek M; Zhang Z; Caravan P
J Am Chem Soc; 2012 Dec; 134(48):19858-68. PubMed ID: 23157602
[TBL] [Abstract][Full Text] [Related]
14. Gadolinium-labeled peptide dendrimers with controlled structures as potential magnetic resonance imaging contrast agents.
Luo K; Liu G; She W; Wang Q; Wang G; He B; Ai H; Gong Q; Song B; Gu Z
Biomaterials; 2011 Nov; 32(31):7951-60. PubMed ID: 21784511
[TBL] [Abstract][Full Text] [Related]
15. Self-assembling DNA quadruplex conjugated to MRI contrast agents.
Cai J; Shapiro EM; Hamilton AD
Bioconjug Chem; 2009 Feb; 20(2):205-8. PubMed ID: 19125646
[TBL] [Abstract][Full Text] [Related]
16. A Gadolinium(III) Complex Based on the Thymine Nucleobase with Properties Suitable for Magnetic Resonance Imaging.
Orts-Arroyo M; Ten-Esteve A; Ginés-Cárdenas S; Castro I; Martí-Bonmatí L; Martínez-Lillo J
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925589
[TBL] [Abstract][Full Text] [Related]
17. Cyclen-based Gd
Rashid HU; Martines MAU; Jorge J; de Moraes PM; Umar MN; Khan K; Rehman HU
Bioorg Med Chem; 2016 Nov; 24(22):5663-5684. PubMed ID: 27729196
[TBL] [Abstract][Full Text] [Related]
18. Zwitterionic Gadolinium(III)-Complexed Dendrimer-Entrapped Gold Nanoparticles for Enhanced Computed Tomography/Magnetic Resonance Imaging of Lung Cancer Metastasis.
Liu J; Xiong Z; Zhang J; Peng C; Klajnert-Maculewicz B; Shen M; Shi X
ACS Appl Mater Interfaces; 2019 May; 11(17):15212-15221. PubMed ID: 30964632
[TBL] [Abstract][Full Text] [Related]
19. A multimeric MR-optical contrast agent for multimodal imaging.
Harrison VS; Carney CE; Macrenaris KW; Meade TJ
Chem Commun (Camb); 2014 Oct; 50(78):11469-71. PubMed ID: 25137290
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and relaxivity studies of a tetranuclear gadolinium(III) complex of DO3A as a contrast-enhancing agent for MRI.
Jebasingh B; Alexander V
Inorg Chem; 2005 Dec; 44(25):9434-43. PubMed ID: 16323930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
